The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Med.
Sec. Infectious Diseases: Pathogenesis and Therapy
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1448147
Continuous debridement combined with short-term posaconazole therapy for Cutaneous Mucormycosis caused by Rhizopus oryzae infection secondary to acute myeloid leukemia: A Case Report
Provisionally accepted- 1 Department of Hematopathology, Shangyu People's Hospital of Shaoxing, Shaoxing, China
- 2 Shangyu People's Hospital of Shaoxing, Shaoxing, Zhejiang Province, China
- 3 Department of infectious diseases, Shangyu people's Hospital Of Shaoxing, shaoxing, China
- 4 Department of Infectious Diseases, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China
Cutaneous mucormycosis is a rare fungal infection marked by skin abscesses, swelling, necrosis, dry ulcers, and eschars. Though less fatal compared to other mucormycosis forms, delayed diagnosis and treatment in immunocompromised patients can cause the infection to spread to vital organs, becoming life-threatening. We report a case of lower extremity cutaneous mucormycosis secondary to acute myeloid leukemia, successfully managed with sustained surgical debridement and short-term oral posaconazole. This case highlights the effectiveness of surgical debridement and the potential for short-course antifungal therapy in managing cutaneous mucormycosis.
Keywords: Cutaneous Mucormycosis1, Lower Limb Infection2, acute myeloid leukemia3, Posaconazole4, Case report5
Received: 12 Jun 2024; Accepted: 11 Oct 2024.
Copyright: © 2024 Wang, Li, ye and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
jiayuan ye, Department of infectious diseases, Shangyu people's Hospital Of Shaoxing, shaoxing, China
Yilian Xie, Department of Infectious Diseases, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.